Princeton, Illinois Clinical Trials

A listing of Princeton, Illinois clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 105 clinical trials
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

This randomized phase III trial studies how well doxorubicin hydrochloride and cyclophosphamide followed by paclitaxel with or without carboplatin work in treating patients with triple-negative breast cancer. Drugs used in chemotherapy, such as doxorubicin hydrochloride, cyclophosphamide, paclitaxel, and carboplatin, work in different ways to stop the growth of tumor cells, …

neutrophil count
ductal carcinoma in situ
pet/ct scan
absolute neutrophil count
estrogen
Illinois CancerCare-Princeton
 (2.0 away) Contact site
  • 814 views
  • 24 Jan, 2021
  • +810 other locations
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors Lymphomas or Multiple Myeloma (The MATCH Screening Trial)

This phase II MATCH trial studies how well treatment that is directed by genetic testing works in patients with solid tumors or lymphomas that have progressed following at least one line of standard treatment or for which no agreed upon treatment approach exists. Genetic tests look at the unique genetic …

gnrh
neutrophil count
larotrectinib
tubal ligation
major surgery
Illinois CancerCare-Princeton
 (2.0 away) Contact site
  • 6097 views
  • 26 Sep, 2021
  • +1027 other locations
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy

This randomized phase III trial studies how well cisplatin or carboplatin (platinum based chemotherapy) works compared to capecitabine in treating patients with remaining (residual) basal-like triple-negative breast cancer following chemotherapy after surgery (neoadjuvant). Drugs used in chemotherapy, such as cisplatin, carboplatin and capecitabine, work in different ways to stop the …

gnrh
neutrophil count
ductal carcinoma in situ
tubal ligation
experimental drug
Illinois CancerCare-Princeton
 (2.0 away) Contact site
  • 513 views
  • 24 Jan, 2021
  • +702 other locations
Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer

This randomized phase III trial studies how well paclitaxel, trastuzumab, and pertuzumab with or without atezolizumab works in treating patients with breast cancer that has spread to other parts of the body (metastatic). Chemotherapy drugs, such as paclitaxel, work in different ways to stop the growth of tumor cells, either …

pertuzumab
monoclonal antibodies
neutrophil count
stage iv breast cancer
metastasis
Illinois CancerCare-Princeton
 (2.0 away) Contact site
  • 445 views
  • 26 Sep, 2021
  • +464 other locations
Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer

This phase III trial studies whether pembrolizumab alone as a first-line treatment, followed by pemetrexed and carboplatin with or without pembrolizumab after disease progression is superior to induction with pembrolizumab, pemetrexed and carboplatin followed by pembrolizumab and pemetrexed maintenance in treating patients with stage IV non-squamous non-small cell lung cancer. …

cardiac disease
neutrophil count
insulin
aptt
ROS1
Illinois CancerCare-Peru
 (17.6 away) Contact site
  • 213 views
  • 26 Sep, 2021
  • +831 other locations
Active Surveillance Bleomycin Carboplatin Etoposide or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

This phase III trial studies how well active surveillance, bleomycin, carboplatin, etoposide, or cisplatin work in treating pediatric and adult patients with germ cell tumors. Active surveillance may help doctors to monitor subjects with low risk germ cell tumors after their tumor is removed. Drugs used in chemotherapy, such as …

neutrophil count
mg++
tumor markers
primary tumor
immature teratoma
Illinois CancerCare-Princeton
 (2.0 away) Contact site
  • 341 views
  • 08 Sep, 2021
  • +370 other locations
Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery

This randomized phase II/III trial studies docetaxel, antiandrogen therapy, and radiation therapy to see how well it works compared with antiandrogen therapy and radiation therapy alone in treating patients with prostate cancer that has been removed by surgery. Androgen can cause the growth of prostate cells. Antihormone therapy may lessen …

Illinois CancerCare-Princeton
 (2.0 away) Contact site
  • 1468 views
  • 27 Sep, 2021
  • +339 other locations
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

This phase II trial studies nivolumab and ipilimumab in treating patients with rare tumors. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial enrolls participants for …

neutrophil count
carcinosarcoma
tubal ligation
autoimmune disease
parathyroid
Illinois CancerCare-Princeton
 (2.0 away) Contact site
  • 6048 views
  • 26 Sep, 2021
  • +817 other locations
A Phase II/III Trial of Nivolumab Ipilimumab and GM-CSF in Patients With Advanced Melanoma

This phase II/III trial studies the side effects of nivolumab and ipilimumab when given together with or without sargramostim and to see how well they work in treating patients with stage III-IV melanoma that cannot be removed by surgery (unresectable). Immunotherapy with monoclonal antibodies, such as ipilimumab and nivolumab, may …

monoclonal antibodies
absolute neutrophil count
white blood cell count
metastasis
interferon
Illinois CancerCare-Peru
 (17.6 away) Contact site
  • 46 views
  • 26 Sep, 2021
  • +436 other locations
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

This randomized research trial studies how well serum tumor marker directed disease monitoring works in monitoring patients with hormone receptor positive Her2 negative breast cancer that has spread to other places in the body. Using markers to prompt when scans should be ordered may be as good as the usual …

Illinois CancerCare-Princeton
 (2.0 away) Contact site
  • 139 views
  • 19 May, 2021
  • +481 other locations